Research dossier

GHK-Cu, the copper peptide — copper complex and extracellular matrix dossier

The copper peptide: a tripeptide forming a copper(II) complex of defined geometry, studied in matrix remodelling.

8 min read · Purpeptide Research Desk ·

Translated from the French original, which remains the reference version: lire en français →

GHK-Cu — research dossier illustration

Molecular identity

ParameterValue
CAS number89030-95-5
Molar mass402.92 g/mol
Molecular formulaC₁₄H₂₃CuN₆O₄
Sequence / natureGly-His-Lys (chelated to Cu²⁺)
Purity≥99%
AppearanceWhite lyophilised powder

The values above correspond to the catalogue lot and are reproduced as they stand from the product page. Any discrepancy between this dossier and the product page should be reported before use.

Research context

GHK-Cu is one of the best characterised peptide-metal complexes, and it serves as a model for the broader question of the role of metal ions in peptide activity. The published transcriptomic work on fibroblasts constitutes one of the most complete data sets available for a compound in this category.

Mechanism studied

GHK-Cu is a complex between the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The peptide alone and the copper complex are not equivalent: it is the coordination of copper by the imidazole nitrogen of the histidine and by the alpha-amino nitrogen that defines the geometry of the complex, and the literature attributes most of the described activity to this complexed form.

The published in-vitro work has examined gene expression in cultured dermal fibroblasts, by DNA microarray and RT-qPCR. The gene families most frequently reported concern type I collagen synthesis, matrix metalloproteinases (MMP) and their tissue inhibitors (TIMP) — the MMP/TIMP balance being the classic determinant of extracellular matrix remodelling.

Copper itself is a cofactor of lysyl oxidase, an enzyme involved in the cross-linking of collagen and elastin; the literature discusses the respective contributions of the peptide and of its metal ion to the observed effects, without unanimous conclusion.

In-vitro literature

The models reported are mostly cultures of human dermal fibroblasts and reconstructed skin models. Protocols vary appreciably in the free copper concentration of the medium, a recognised confounding variable in this field.

Bibliographic entry points

These links are an entry point into the literature, not an edited selection. None of the sources cited relates to a human use of this material, and consulting them directly is recommended for any protocol design.

Distinguishing this compound from its analogues

The uncomplexed GHK tripeptide and the GHK-Cu complex are two distinct entities with different properties. The blue colour indicates complexation but does not quantify its degree.

The CAS number shown on the product page is the identifier to rely on. Trade names, development codes and customary abbreviations vary from one source to another and are not a reliable identification.

Routes of administration used in the literature

A substantial part of the research on GHK-Cu concerns the topical route, the copper tripeptide having been studied in cutaneous formulation in work on matrix remodelling. The literature also includes work using parenteral administration — by injection — in laboratory animals, notably in wound healing models.

These two routes answer distinct experimental questions. The topical route interrogates local action on tissue; injection, in animal models, interrogates systemic exposure. Queries such as “GHK-Cu injection”, “GHK-Cu injections” or “copper peptides injection” refer to this second category of experimental work. GHKCu, GHK-Cu and “copper peptide” all designate the same complex there. Results obtained by one route do not transfer to the other.

Three points frame this section, and they are decisive.

These are published experimental protocols, carried out in a laboratory or on an animal model within an ethically supervised framework. They describe what researchers did, not what should be done.

Copper is a transition metal. GHK-Cu is not a simple peptide but a chelated complex, and the fate of the copper governs its profile. That is a difference in kind from non-metallic peptides, and the reason extrapolation between routes is particularly hazardous here.

The material we supply is an in-vitro analytical standard. It is intended neither for humans nor for animals, and no route of administration is proposed, described or recommended for it. The reconstitution documented on this site is a sample preparation operation for analysis — the reconstitution guide contains no administration protocol.

Methodological limits

Free copper in the culture medium is a major confounding variable and is frequently uncontrolled. An effect attributed to the complex may be due to copper alone; the appropriate control is to expose the cells to an equimolar copper source without peptide. Publications lacking that control arm do not support a conclusion.

These limits are not formalities: they determine what a protocol using this material can and cannot establish. Making them explicit in the experimental plan avoids attributing to the compound an observation that belongs to the measurement system.

Analytical parameters

The characteristic blue colour of the complex is a visual indicator of copper coordination, but it is not a purity criterion. Chromatographic analysis addresses the peptide fraction.

ParameterValue
StorageStore at −20 °C, protected from light
SolubilitySoluble in bacteriostatic water (BAC)
StabilityStable for 24 months at −20 °C; 30 days after reconstitution at 2–8 °C
Control methodsRP-HPLC · MS · NMR

Reconstitution is a matter for the experimental protocol. The volume of solvent determines the final concentration and is not prescribed here: it depends on the design of the experiment and the conditions of the assay.

Resulting concentrations

The table below is arithmetic: it gives the concentration obtained for a given solvent volume, with no recommendation of use.

Format1 ml2 ml3 ml
50mg50.00 mg/ml25.00 mg/ml16.67 mg/ml
100mg100.00 mg/ml50.00 mg/ml33.33 mg/ml

These values assume complete dissolution and a peptide content consistent with the lot report. Where the actual quantitative content differs from the nominal mass — a common discrepancy, caused by counter-ions and residual water — the effective concentration is lower than the theoretical value. That is precisely why quantitative content per vial forms part of the verification protocol.

Protocol design

Three points govern the validity of an assay using this material, whatever the question being asked.

The effective concentration is not the nominal concentration. It depends on the actual peptide content of the lot, on complete dissolution and on adsorption to the walls of the container. A concentration check after reconstitution is preferable to assuming a perfect yield.

The actual exposure time may be shorter than the nominal duration where the compound is degraded by the medium. Verify stability under the exact conditions of the assay — medium, serum, temperature, duration — before interpreting an absence of effect.

The control arm must correspond to the vehicle actually used, at the same final concentration. This requirement is unremarkable and remains the most frequent cause of irreproducible results.

Lot verification

The following formats are covered by a Janoshik Analytical report, readable from the product page:

  • 50mg — lot report available
  • 100mg — lot report available
FormatLot reportAvailability
50mgCoveredIn stock
100mgCoveredIn stock

The verification programme covers exclusively the identity and purity of the material, by reversed-phase chromatography and mass spectrometry. It covers neither sterility, nor endotoxins, nor any microbiological characteristic.

Frequently asked questions

How does this product arrive?

As a lyophilised powder in a sealed vial, shipped in insulated, plain packaging. Return the vial to the storage temperature given in the specifications on receipt.

Which solvent should be used for reconstitution?

Bacteriostatic water is the usual reconstitution solvent for lyophilised peptides in a laboratory setting. The volume is a matter for the experimental protocol and the concentration sought; we provide no dosage recommendation.

How long does the material remain stable?

The stability window appears in the specifications table on this page, before and after reconstitution. Those values correspond to the storage conditions stated; any temperature variation shortens them.

Does the analysis report correspond exactly to my vial?

The report linked on this page corresponds to the format selected. Each report is issued by Janoshik Analytical from an anonymously submitted sample, and covers the identity and purity of the peptide.

Can this product be used on humans or animals?

No. It is an analytical grade reference material intended exclusively for in-vitro laboratory research. Any administration to humans or animals is excluded, and no therapeutic, diagnostic or medical claim is made.

See also: Copper peptides: GHK-Cu, AHK-Cu and Snap-8 compared

Dossiers in the same category

Related dossiers

All research dossiers → · Catalogue → · Glossary →